Baker, B R <br/><br/>
Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.  [electronic resource] 

 -  Journal of medicinal chemistry  Mar 1969 
 - 224-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-2623 
<br/><br/><label>Standard No.: </label>10.1021/jm00302a007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Binding Sites<br/>Fluorides--chemical synthesis<br/>Folic Acid Antagonists<br/>In Vitro Techniques<br/>Leukemia L1210--enzymology<br/>Liver--enzymology<br/>Mice<br/>Pyrimidines--chemical synthesis<br/>Sulfones--chemical synthesis